UnknownPhase 3NCT00002549
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Robert A. Zittoun, MD, MDHotel Dieu de Paris
- Intervention
- filgrastim(biological)
- Enrollment
- 1520 enrolled
- Eligibility
- 15-60 years · All sexes
- Timeline
- 1993
Study locations (30)
- Universitaetsklinik, Innsbruck, Austria
- Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
- A.Z. St. Jan, Bruges, Belgium
- Hopital Universitaire Erasme, Brussels, Belgium
- Institut Jules Bordet, Brussels (Bruxelles), Belgium
- Universitair Ziekenhuis Antwerpen, Edegem, Belgium
- CHU Sart-Tilman, Liège, Belgium
- University Hospital Rebro, Zagreb, Croatia
- Medical School/University of Zagreb, Zagreb (Agram), Croatia
- University Hospital - Olomouc, Olomouc, Czechia
- Institute of Hematology and Blood Transfusion, Prague, Czechia
- Hopital Edouard Herriot, Lyon, France
- Centre Antoine Lacassagne, Nice, France
- Hotel Dieu de Paris, Paris, France
- Hopital Cochin, Paris, France
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002549 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.